{"organizations": [], "uuid": "276d4be5b9ac18dfa5abd024941e585de58edf4a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-uniqure-receives-orphan-medicinal/brief-uniqure-receives-orphan-medicinal-product-designation-in-europe-for-amt-130-in-huntingtons-disease-idUSFWN1PH0MW", "country": "US", "domain_rank": 408, "title": "BRIEF-Uniqure Receives Orphan Medicinal Product Designation In Europe For Amt-130 In Huntington’S Disease", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-22T14:04:00.000+02:00", "replies_count": 0, "uuid": "276d4be5b9ac18dfa5abd024941e585de58edf4a"}, "author": "", "url": "https://www.reuters.com/article/brief-uniqure-receives-orphan-medicinal/brief-uniqure-receives-orphan-medicinal-product-designation-in-europe-for-amt-130-in-huntingtons-disease-idUSFWN1PH0MW", "ord_in_thread": 0, "title": "BRIEF-Uniqure Receives Orphan Medicinal Product Designation In Europe For Amt-130 In Huntington’S Disease", "locations": [], "entities": {"persons": [], "locations": [{"name": "europe", "sentiment": "none"}, {"name": "huntington", "sentiment": "none"}, {"name": "europe", "sentiment": "none"}, {"name": "huntington", "sentiment": "none"}], "organizations": [{"name": "huntington’s disease reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 22, 2018 / 12:05 PM / Updated 6 minutes ago BRIEF-Uniqure Receives Orphan Medicinal Product Designation In Europe For Amt-130 In Huntington’S Disease Reuters Staff 1 Min Read \nUniqure Nv: \n* UNIQURE RECEIVES ORPHAN MEDICINAL PRODUCT DESIGNATION IN EUROPE FOR AMT-130 IN HUNTINGTON’S DISEASE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-22T14:04:00.000+02:00", "crawled": "2018-01-22T15:01:34.024+02:00", "highlightTitle": ""}